ImmuCell Corporation Sales Revenue, Goods, Net (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $2.88 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-14
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $2.88M, a 18.70% decline year-over-year.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.13M, a 41.50% increase year-over-year.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.00M, a 1.87% increase year-over-year.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $1.75M, a 26.35% decline year-over-year.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $10.43M, a 9.30% increase from fiscal 2016.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $9.54M, a 6.69% decline from fiscal 2015.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $10.23M, a 34.64% increase from fiscal 2014.
- ImmuCell Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $7.60M, a 26.46% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $2.88M 10-Q · filed 2018-05-14 | $6.01M derived: sum of 2 quarters · filed 2018-05-14 | $8.02M derived: sum of 3 quarters · filed 2018-05-14 | $9.77M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $5.14M derived: sum of 2 quarters · filed 2018-03-29 | $6.89M derived: sum of 3 quarters · filed 2018-03-29 | $10.43M 10-K · filed 2018-03-29 |
| 2017-09-30 | $2.00M 10-Q · filed 2017-11-13 | $3.75M derived: sum of 2 quarters · filed 2017-11-13 | $7.30M 10-Q · filed 2017-11-13 | $9.51M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-06-30 | $1.75M 10-Q · filed 2017-08-14 | $5.29M 10-Q · filed 2017-08-14 | $7.51M derived: sum of 3 quarters · filed 2018-05-14 | $9.48M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-03-31 | $3.54M 10-Q · filed 2018-05-14 | $5.76M derived: sum of 2 quarters · filed 2018-05-14 | $7.73M derived: sum of 3 quarters · filed 2018-05-14 | $10.10M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $2.21M 10-K · filed 2017-03-30 | $4.18M derived: sum of 2 quarters · filed 2017-11-13 | $6.56M derived: sum of 3 quarters · filed 2017-11-13 | $9.54M 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.97M 10-Q · filed 2017-11-13 | $4.34M derived: sum of 2 quarters · filed 2017-11-13 | $7.33M 10-Q · filed 2017-11-13 | $10.02M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $2.38M 10-Q · filed 2017-08-14 | $5.36M 10-Q · filed 2017-08-14 | $8.06M derived: sum of 3 quarters · filed 2017-08-14 | $10.53M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $2.99M 10-Q · filed 2017-05-11 | $5.68M derived: sum of 2 quarters · filed 2017-05-11 | $8.15M derived: sum of 3 quarters · filed 2017-05-11 | $10.11M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $2.69M 10-K · filed 2017-03-30 | $5.17M derived: sum of 2 quarters · filed 2017-03-30 | $7.13M derived: sum of 3 quarters · filed 2017-03-30 | $10.23M 10-K · filed 2017-03-30 |
| 2015-09-30 | $2.47M 10-K · filed 2017-03-30 | $4.43M derived: sum of 2 quarters · filed 2017-03-30 | $7.53M 10-Q · filed 2016-11-10 | $9.74M derived: sum of 4 quarters · filed 2017-03-30 |
| 2015-06-30 | $1.96M 10-K · filed 2017-03-30 | $5.06M 10-Q · filed 2016-08-11 | $7.27M derived: sum of 3 quarters · filed 2017-03-30 | $9.04M derived: sum of 4 quarters · filed 2017-03-30 |
| 2015-03-31 | $3.10M 10-K · filed 2017-03-30 | $5.31M derived: sum of 2 quarters · filed 2017-03-30 | $7.08M derived: sum of 3 quarters · filed 2017-03-30 | $8.62M derived: sum of 4 quarters · filed 2017-03-30 |
| 2014-12-31 | $2.21M 10-K · filed 2016-03-25 | $3.98M derived: sum of 2 quarters · filed 2016-03-25 | $5.52M derived: sum of 3 quarters · filed 2016-03-25 | $7.60M 10-K · filed 2016-03-25 |
| 2014-09-30 | $1.77M 10-K · filed 2016-03-25 | $3.31M derived: sum of 2 quarters · filed 2016-03-25 | $5.39M 10-Q · filed 2015-11-12 | $6.95M derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-06-30 | $1.54M 10-K · filed 2016-03-25 | $3.62M 10-Q · filed 2015-08-13 | $5.18M derived: sum of 3 quarters · filed 2016-03-25 | $6.42M derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-03-31 | $2.08M 10-K · filed 2016-03-25 | $3.64M derived: sum of 2 quarters · filed 2016-03-25 | $4.88M derived: sum of 3 quarters · filed 2016-03-25 | $6.24M derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-12-31 | $1.56M 10-K · filed 2016-03-25 | $2.79M derived: sum of 2 quarters · filed 2016-03-25 | $4.16M derived: sum of 3 quarters · filed 2016-03-25 | $6.01M 10-K · filed 2016-03-25 |
| 2013-09-30 | $1.23M 10-K · filed 2016-03-25 | $2.60M derived: sum of 2 quarters · filed 2016-03-25 | $4.45M 10-Q · filed 2014-11-12 | $5.87M derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-06-30 | $1.37M 10-K · filed 2016-03-25 | $3.21M 10-Q · filed 2014-08-13 | $4.63M derived: sum of 3 quarters · filed 2016-03-25 | $5.71M derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-03-31 | $1.85M 10-K · filed 2016-03-25 | $3.27M derived: sum of 2 quarters · filed 2016-03-25 | $4.34M derived: sum of 3 quarters · filed 2016-03-25 | $5.52M derived: sum of 4 quarters · filed 2016-03-25 |
| 2012-12-31 | $1.42M 10-K · filed 2015-03-26 | $2.50M derived: sum of 2 quarters · filed 2015-03-26 | $3.67M derived: sum of 3 quarters · filed 2015-03-26 | $5.39M 10-K · filed 2015-03-26 |
| 2012-09-30 | $1.08M 10-K · filed 2015-03-26 | $2.25M derived: sum of 2 quarters · filed 2015-03-26 | $3.97M 10-Q · filed 2013-11-13 | $5.27M derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-06-30 | $1.18M 10-K · filed 2015-03-26 | $2.89M 10-Q · filed 2013-08-13 | $4.20M derived: sum of 3 quarters · filed 2015-03-26 | $5.20M derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-03-31 | $1.72M 10-K · filed 2015-03-26 | $3.02M derived: sum of 2 quarters · filed 2015-03-26 | $4.03M derived: sum of 3 quarters · filed 2015-03-26 | $5.27M derived: sum of 4 quarters · filed 2015-03-26 |
| 2011-12-31 | $1.30M 10-K · filed 2014-03-26 | $2.31M derived: sum of 2 quarters · filed 2014-03-26 | $3.56M derived: sum of 3 quarters · filed 2014-03-26 | $5.11M 10-K · filed 2014-03-26 |
| 2011-09-30 | $1.00M 10-K · filed 2014-03-26 | $2.25M derived: sum of 2 quarters · filed 2014-03-26 | $3.81M 10-Q · filed 2012-11-13 | $4.93M derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-06-30 | $1.25M 10-K · filed 2014-03-26 | $2.80M 10-Q/A · filed 2012-09-07 | $3.93M derived: sum of 3 quarters · filed 2014-03-26 | $4.80M derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-03-31 | $1.56M 10-K · filed 2014-03-26 | $2.68M derived: sum of 2 quarters · filed 2014-03-26 | $3.55M derived: sum of 3 quarters · filed 2014-03-26 | $4.63M derived: sum of 4 quarters · filed 2014-03-26 |
| 2010-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $2.00M derived: sum of 2 quarters · filed 2013-03-28 | $3.07M derived: sum of 3 quarters · filed 2013-03-28 | $4.39M 10-K · filed 2013-03-28 |
| 2010-09-30 | $873.72K 10-Q · filed 2011-11-14 | $1.95M derived: sum of 2 quarters · filed 2011-11-14 | $3.26M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $1.08M 10-Q · filed 2011-08-15 | $2.39M 10-Q · filed 2011-08-15 | ||
| 2009-12-31 | $4.51M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |